Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies

• Swati Verma,

  Affiliation Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  ⨯
• Jackeline Soto,

  Affiliation Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  ⨯
• Anupama Vasudevan,

  Affiliation Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  ⨯
• Falko Schmeisser,

  Affiliation Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  ⨯
• Esmeralda Alvarado-Facundo,

  Affiliation Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  ⨯
• Wei Wang,

  Affiliation Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  ⨯
• Carol D. Weiss,

  Affiliation Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  ⨯
• Jerry P. Weir

  * E-mail: jerry.weir@fda.hhs.gov

  Affiliation Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States of America

  http://orcid.org/0000-0002-0260-0996

  ⨯